[ad_1]
“We are proud to be recognized by some of the most important and influential members of the cannabis industry – retailers and future workers,” he says Geoff Hoover, senior vice president of consumer affairs at Aurora Cannabis. “This award is a testament to our continued commitment to quality and our team’s unwavering focus and passion to deliver only the best products for our consumers.”
Greybeard was also nominated for ‘Best in Vape Cartridge of the Year’, ‘Rollophony of the Year’ and ‘Resin of the Year’. Aurora’s San Rafael ’71 brand is also nominated in the ‘Resin of the Year’ category.
For more information about Aurora and its portfolio of brands, visit auroramj.com.
About Aurora:
Aurora is a global leader in the cannabis industry, serving both the medical and consumer markets. Based in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company’s adult brand portfolio includes Aurora Drift, San Rafael ’71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. Aurora also has a controlling interest in Bevo Farms, North America a leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora’s brands continue to break out as industry leaders in the medical, performance, wellness and adult recreation markets wherever they are launched. Learn more at www.auroramj.com and follow us Twitter and LinkedIn.
Aurora’s common stock trades on the NASDAQ and TSX under the symbol “ACB”.
Forward looking information
This press release includes statements that contain certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are often characterized by words such as “plan,” “continue,” “expect,” “project,” “intend,” “believe,” “anticipate,” “estimate,” “may,” ” will”, “potential”, “proposed” and other similar words or statements that certain events or conditions “may” or “will occur”.
These forward-looking statements are only predictions. Forward-looking information or statements contained in this press release have been developed based on assumptions that management believes to be reasonable. Material factors or assumptions involved in making forward-looking statements include, without limitation, publicly available information from government sources, as well as from market research and industry analysis and assumptions based on data and knowledge of the industry that the Company believes to be reasonable. Forward-looking statements are subject to various risks, uncertainties and other factors that management believes to be relevant and reasonable under the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially. differ from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of government and non-government consumer sales channels third parties, consumer demand management assessments in Canada and in jurisdictions to which the Company exports, expectations of future results and costs, risk of successful integration of the acquired business and business, management’s assessment that SG&A will grow only in proportion to revenue growth, ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial conditions the market, returns from cannabis cultivation operations, demand for products, changes in prices of required commodities, competition and the possibility of changes in laws, rules and regulations in the industry, epidemics, pandemics or other public health crises, including the current outbreak of COVID-19, and other risks, uncertainties and the factors listed under the heading “Risk Factors” in the Company’s annual information form dated September 30, 2022 (“AIF”) and filed with Canadian securities regulators available on the company’s issuer profile on SEDAR at www.sedar.com and filed and available on the SEC’s website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and that other factors may also adversely affect its results. Readers are urged to carefully consider the risks, uncertainties and assumptions when evaluating forward-looking statements and are cautioned not to place undue reliance on such information. The Company undertakes no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. .
SOURCE Aurora Cannabis Inc.
For further information: To the media: Michelle Leffler, Vice President of Communications and Public Relations, [email protected]; For Investors: ICR, Inc., Investor Relations, [email protected]
[ad_2]
Source link
